Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars
NCT ID: NCT06375941
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
250 participants
OBSERVATIONAL
2024-03-29
2034-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study on Epithelioid Sarcoma
NCT03099681
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
NCT02547831
REtroperitoneal SArcoma Registry: an International Prospective Initiative
NCT03838718
An Observational Study of Local Relapse After High Grade Osteosarcoma
NCT06017518
Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District
NCT06872853
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These issues may be addressed with a prospective multi-institutional observational study, through the collection of clinical and pathological data of patients with localized AS.
Involving all reference centres for sarcoma in Italy, the Italian Sarcoma Group (ISG) will be the ideal network for this study, with the collaboration of the Italian Rare Cancer Network (RTR), a 7collaborative network among Italian centres focusing on improving the quality of care of patients with rare tumors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pathological diagnosis of AS, any site of origin, any age, primary, localized, resectable disease.
* pathological diagnosis of AS;
* any site of origin;
* any age;
* primary, localized, resectable disease.
Observational
Observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational
Observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* any site of origin;
* any age;
* primary, localized, resectable disease.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Italian Sarcoma Group
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Palassini
Role: PRINCIPAL_INVESTIGATOR
IRCCS Istituto nazionale Tumori - Milano
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Clinico Humanitas Research Hospital IRCCS
Rozzano, Milano, Italy
Centro Riferimento Oncologico CRO
Aviano, Pordenone, Italy
AOU San Luigi Gonzaga
Orbassano, Torino, Italy
Istituto Tumori "Giovanni Paolo II" I.R.C.C.S.
Bari, , Italy
Istituto Ortopedico Rizzoli IOR
Bologna, , Italy
Policlinico "Sant'Orsola-Malpighi"
Bologna, , Italy
A.O.U. Careggi
Florence, , Italy
Ospedale Policlinico san Martino IRCCS
Genova, , Italy
IRCCS Istituto Nazionale Tumori - Milano
Milan, , Italy
IRCCS Istituto Europeo di Oncologia
Milan, , Italy
Fondazione Irccs San Gerardo Dei Tintori
Monza, , Italy
Istituto Nazionale Tumori_Fondazione "G.Pascale"
Napoli, , Italy
IOV Istituto Oncologico Veneto IRCCS
Padua, , Italy
Policlinico "Paolo Giaccone"
Palermo, , Italy
Nuovo Ospedale di Prato - S. Stefano
Prato, , Italy
Fondazione Policlinico Campus Biomedico
Roma, , Italy
IRCCS Istituti Fisioterapici Ospitalieri
Roma, , Italy
ASL Ospedale San Giovanni Bosco
Torino, , Italy
Ospedale di Trento
Trento, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alexia Bertuzzi, MD
Role: primary
Federico Navarria, MD
Role: primary
Lorenzo D'Ambrosio, MD
Role: primary
Sabino Strippoli, MD
Role: primary
Toni Ibrahim, MD
Role: primary
Maria Abbondanza Pantaleo, Prof.
Role: primary
Lorenzo Livi, MD
Role: primary
Danila Comandini, MD
Role: primary
Palassini Elena
Role: primary
Elisabetta Pennacchioli, MD
Role: primary
Marinella Mastore, MD
Role: primary
Lucia Cannella, MD
Role: primary
Antonella Brunello
Role: primary
Giuseppe Badalamenti, Prof.
Role: primary
Giacomo Giulio Baldi
Role: primary
Bruno Vincenzi, prof
Role: primary
Virginia Ferraresi, MD
Role: primary
Antonella Boglione, MD
Role: primary
Marco Cianchetti, MD
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Italian Sarcoma Group website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ProStars
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.